ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Human medicines European public assessment report (EPAR): Idelvion, albutrepenonacog alfa, Hemophilia B, Date of authorisation: 11/05/2016, Revision: 4, Status: Authorised
Case Medical Research
◽
10.31525/cmr-8ecce9
◽
2019
◽
Author(s):
Keyword(s):
Hemophilia B
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Related Documents
Cited By
References
Human medicines European public assessment report (EPAR): Idelvion, albutrepenonacog alfa, Hemophilia B, Date of authorisation: 11/05/2016, Revision: 5, Status: Authorised
Case Medical Research
◽
10.31525/cmr-8e0202
◽
2019
◽
Author(s):
Keyword(s):
Hemophilia B
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): NovoSeven, eptacog alfa (activated), Hemophilia B,Thrombasthenia,Factor VII Deficiency,Hemophilia A, Date of authorisation: 23/02/1996, Revision: 32, Status: Authorised
Case Medical Research
◽
10.31525/cmr-6ac70d
◽
2019
◽
Author(s):
Keyword(s):
Hemophilia A
◽
Hemophilia B
◽
Factor Vii
◽
Assessment Report
◽
Factor Vii Deficiency
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Alprolix, eftrenonacog alfa, Hemophilia B, Date of authorisation: 12/05/2016, Revision: 4, Status: Authorised
Case Medical Research
◽
10.31525/cmr-fcd084
◽
2019
◽
Author(s):
Keyword(s):
Hemophilia B
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Alprolix, eftrenonacog alfa, Hemophilia B, Date of authorisation: 12/05/2016, Revision: 4, Status: Authorised
Case Medical Research
◽
10.31525/cmr-fcb386
◽
2019
◽
Author(s):
Keyword(s):
Hemophilia B
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Nonafact, human coagulation factor IX, Hemophilia B, Date of authorisation: 03/07/2001, Revision: 9, Status: Withdrawn
Case Medical Research
◽
10.31525/cmr-29b43ac
◽
2020
◽
Author(s):
Keyword(s):
Coagulation Factor
◽
Factor Ix
◽
Hemophilia B
◽
Assessment Report
◽
Coagulation Factor Ix
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Rixubis, nonacog gamma, Hemophilia B, Date of authorisation: 19/12/2014, Revision: 7, Status: Authorised
Case Medical Research
◽
10.31525/cmr-2249a9d
◽
2019
◽
Author(s):
Keyword(s):
Hemophilia B
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): BeneFIX, nonacog alfa, Hemophilia B, Date of authorisation: 27/08/1997, Revision: 38, Status: Authorised
Case Medical Research
◽
10.31525/cmr-399687
◽
2019
◽
Author(s):
Keyword(s):
Hemophilia B
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Rixubis, nonacog gamma, Hemophilia B, Date of authorisation: 19/12/2014, Revision: 7, Status: Authorised
Case Medical Research
◽
10.31525/cmr-223e99a
◽
2019
◽
Author(s):
Keyword(s):
Hemophilia B
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): NovoSeven, eptacog alfa (activated), Hemophilia B,Thrombasthenia,Factor VII Deficiency,Hemophilia A, Date of authorisation: 23/02/1996, Revision: 32, Status: Authorised
Case Medical Research
◽
10.31525/cmr-68b782
◽
2019
◽
Author(s):
Keyword(s):
Hemophilia A
◽
Hemophilia B
◽
Factor Vii
◽
Assessment Report
◽
Factor Vii Deficiency
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): BeneFIX, nonacog alfa, Hemophilia B, Date of authorisation: 27/08/1997, Revision: 38, Status: Authorised
Case Medical Research
◽
10.31525/cmr-91357b
◽
2019
◽
Author(s):
Keyword(s):
Hemophilia B
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close